IND 401 (rev1) Work at height regulations 2005 (as amended). A brief guideSafety Executive
This communication includes express or implied forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Actual events or results may differ materially from ...
as amended. These statements are often, but are not always, made through the use of words or phrases such as “anticipate,”“expect,”“plan,”“estimate,”“will,”“continue,”“aim,”“intend,”“future,...
" which are statements other than historical facts made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements...
Indian Hill C Style and Coding Standards as amended for U of T Zoology UNIX† L.W. Cannon R.A. Elliott L.W. Kirchhoff J.H. Miller J.M. Milner R.W. Mitze E.P. Schan N.O. Whittington Bell Labs Henry Spencer Zoology Computer Systems University of Toronto ABSTRACT This document is...
Statements contained in this press release regarding matters that are not historical facts are “forward‐looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as “anticipates,”“believes,”“expects,”“intends,”“pl...
1Clarifications given or views expressed by the Ind AS Technical Facilitation Group (ITFG) represent the views of the ITFG and are not necessarily the views of the Ind AS Implementation Group or the Council of the Institute. The clarifications/views are based on the a...
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announces the completion of the Pre-IND discussions with the US Food and...
so close to the ocean, created drainage problems in the tunnels and would be too expensive to build. An alternative as part of an amended 1968 Plan for Action called for the line to be extended along Flatbush Ave to Ave U instead, which acted as a compromise between building both this an...
Lantern Pharma Inc. today announced it has received guidance from the United States Food and Drug Administration (FDA) on Lantern’s clinical development plans for its LP-184 program.